These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 9740825)

  • 1. [Treatment of discoid lupus erythematosus with sulfasalazine: 11 cases].
    Delaporte E; Catteau B; Sabbagh N; Gosselin P; Breuillard F; Doutre MS; Broly F; Piette F; Bergoend H
    Ann Dermatol Venereol; 1997; 124(2):151-6. PubMed ID: 9740825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus.
    Tlacuilo-Parra A; Guevara-Gutiérrez E; Gutiérrez-Murillo F; Soto-Ortiz A; Barba-Gómez F; Hernández-Torres M; Salazar-Páramo M
    Rheumatology (Oxford); 2005 Dec; 44(12):1564-8. PubMed ID: 16159951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thalidomide and thrombosis].
    Flageul B; Wallach D; Cavelier-Balloy B; Bachelez H; Carsuzaa F; Dubertret L
    Ann Dermatol Venereol; 2000 Feb; 127(2):171-4. PubMed ID: 10739975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thalidomide therapy for discoid lupus erythematosus].
    Lyakhovisky A; Baum S; Shpiro D; Salomon M; Trau H
    Harefuah; 2006 Jul; 145(7):489-92, 551. PubMed ID: 16900736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus.
    Sabbagh N; Delaporte E; Marez D; Lo-Guidice JM; Piette F; Broly F
    Pharmacogenetics; 1997 Apr; 7(2):131-5. PubMed ID: 9170150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.
    Ordi-Ros J; Cortés F; Cucurull E; Mauri M; Buján S; Vilardell M
    J Rheumatol; 2000 Jun; 27(6):1429-33. PubMed ID: 10852265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adult discoid lupus erythematosus].
    Khelifa E; Benmously R; Fenniche S; Marrak H; Zghal M; Mokhtar I
    Tunis Med; 2007 Mar; 85(3):205-8. PubMed ID: 17668574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic lupus erythematosus with sulfasalazine in 18 patients: reappraisal].
    Duparc A; Staumont-Sallé D; Broly F; Piette F; Delaporte E
    Presse Med; 2006; 35(7-8):1138-42. PubMed ID: 16840889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus.
    Sugano M; Shintani Y; Kobayashi K; Sakakibara N; Isomura I; Morita A
    J Dermatol; 2006 Dec; 33(12):887-91. PubMed ID: 17169097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfasalazine-induced lupus syndrome in a patient with Crohn's disease.
    Carr-Locke DL
    Am J Gastroenterol; 1982 Sep; 77(9):614-6. PubMed ID: 6126117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimecrolimus 1% cream for cutaneous lupus erythematosus.
    Kreuter A; Gambichler T; Breuckmann F; Pawlak FM; Stücker M; Bader A; Altmeyer P; Freitag M
    J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cutaneous lupus erythematosus. Thalidomide treatment of 11 patients.
    Hasper MF
    Arch Dermatol; 1983 Oct; 119(10):812-5. PubMed ID: 6614949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
    Jewell ML; McCauliffe DP
    J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
    Cuadrado MJ; Karim Y; Sanna G; Smith E; Khamashta MA; Hughes GR
    Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
    Woosley RL; Drayer DE; Reidenberg MM; Nies AS; Carr K; Oates JA
    N Engl J Med; 1978 May; 298(21):1157-9. PubMed ID: 306574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of conduction in lupus erythematosus : frequency and incidence in a group of 112 patients (author's transl)].
    Godeau P; Guillevin L; Fechner J; Bletry O; Herreman G
    Ann Med Interne (Paris); 1981; 132(4):234-40. PubMed ID: 7305172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fixed lupus erythematosus (its treatment with thalidomide)].
    Barba Rubio J; Franco González F
    Med Cutan Ibero Lat Am; 1977; 5(4):279-85. PubMed ID: 364211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinuclear antibodies related to acetylator phenotype in mice.
    Tannen RH; Weber WW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):485-90. PubMed ID: 6970809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of "mixed connective tissue disease" (MCTD) from discoid lupus erythematosus].
    Bauer R; Schultz-Ehrenburg U; Orfanos CE
    Hautarzt; 1981 Jan; 32(1):23-7. PubMed ID: 6971860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.